Inventor · disambiguated record
Duane A. Mitchell
Also filed as: MITCHELL DUANE · MITCHELL DUANE A
19 granted patents·21 pending applications·126 citations·filing 2006–2023
94Inventor score
Top patents by PatentIndex Score
40 records- 0197US11389530B2Compositions, methods and kits for eliciting an immune responseUNIV DUKE·Filed 2020·Granted Jul 19, 2022·5 cites·34 claims
- 0297US11376322B2Compositions, methods and kits for eliciting an immune responseUNIV DUKE·Filed 2020·Granted Jul 5, 2022·5 cites·34 claims
- 0397US11364295B2Compositions, methods and kits for eliciting an immune responseUNIV DUKE·Filed 2020·Granted Jun 21, 2022·5 cites·34 claims
- 0497US11351248B2Compositions, methods and kits for eliciting an immune responseUNIV DUKE·Filed 2020·Granted Jun 7, 2022·5 cites·34 claims
- 0597US10632190B2Compositions, methods and kits for eliciting an immune responseUNIV DUKE·Filed 2017·Granted Apr 28, 2020·12 cites·55 claims
- 0697US9764026B2Compositions, methods, and kits for eliciting an immune responseUNIV DUKE·Filed 2015·Granted Sep 19, 2017·19 cites·8 claims
- 0796US9011835B2Compositions, methods, and kits for eliciting an immune responseUNIV DUKE·Filed 2013·Granted Apr 21, 2015·18 cites·10 claims
- 0895US8425898B2Compositions, methods, and kits for eliciting an immune responseSAMPSON JOHN H·Filed 2009·Granted Apr 23, 2013·26 cites·8 claims
- 0988US10660954B2Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancerUNIV FLORIDA·Filed 2016·Granted May 26, 2020·16 cites·26 claims
- 1088US9974848B2Tetanus toxoid and CCL3 improve DC vaccinesUNIV DUKE·Filed 2014·Granted May 22, 2018·8 cites·31 claims
- 1184US12070496B2Compositions, methods and kits for eliciting an immune responseUNIV DUKE·Filed 2022·Granted Aug 27, 2024·0 cites·34 claims
- 1284US2022401552A1Compositions, Methods and Kits for Eliciting an Immune ResponseUNIV DUKE·Filed 2022·Application pending·0 cites
- 1383US2022387582A1Compositions, Methods and Kits for Eliciting an Immune ResponseUNIV DUKE·Filed 2022·Application pending·0 cites
- 1483US2022370602A1Compositions, Methods and Kits for Eliciting an Immune ResponseUNIV DUKE·Filed 2022·Application pending·0 cites
- 1581US9950056B2Compositions, methods and kits for eliciting an immune responseUNIV DUKE·Filed 2014·Granted Apr 24, 2018·5 cites·26 claims
- 1679US11904016B2Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancerUNIV FLORIDA·Filed 2020·Granted Feb 20, 2024·1 cites·22 claims
- 1772US11684662B2Tetanus toxoid and CCL3 improve DC vaccinesUNIV DUKE·Filed 2021·Granted Jun 27, 2023·0 cites·23 claims
- 1871US11674120B2Methods, kits, and compositions for enhancing cellular therapyUNIV FLORIDA·Filed 2017·Granted Jun 13, 2023·1 cites·18 claims
- 1969US12297455B2Methods, kits, and compositions for enhancing cellular therapyUNIV FLORIDA·Filed 2023·Granted May 13, 2025·0 cites·18 claims
- 2068US11071777B2Tetanus toxoid and CCL3 improve DC vaccinesUNIV DUKE·Filed 2018·Granted Jul 27, 2021·0 cites·16 claims
- 2166US2015118181A1Concurrent Chemotherapy and ImmunotherapySAMPSON JOHN H·Filed 2014·Application pending·0 cites
- 2265US9399662B2Concurrent chemotherapy and immunotherapySAMPSON JOHN H·Filed 2006·Granted Jul 26, 2016·0 cites·2 claims
- 2363US2011236345A1Composition and methods for eliciting an immune responseUNIV DUKE·Filed 2009·Application pending·0 cites
- 2460US2025170242A1Chimeric lactate receptor engineered t cellsUNIV FLORIDA·Filed 2023·Application pending·0 cites
- 2559US2009004742A1Selection of antigen-specific t cellsUNIV DUKE·Filed 2008·Application pending·0 cites
- 2659US2022119762A1Cellular micro-masonry systemUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 2758US2018215789A1Concurrent Chemotherapy and ImmunotherapyUNIV DUKE·Filed 2018·Application pending·0 cites
- 2854US2024269262A1Methods, kits, and approaches for viral vaccinesUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 2954US2012244145A1Enhanced immunological responsesSAMPSON JOHN H·Filed 2011·Application pending·0 cites
- 3054US2024108652A1Enhancing metabolic fitness of t cells to treat cancerUNIV FLORIDA·Filed 2022·Application pending·0 cites
- 3150US2023414721A1Materials and methods for sensitizing tumors to immune responseUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 3250US2023183370A1Stem cell immunomodulatory therapy for covid-19 infectionUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 3347US2015307614A1Enhanced immunological responsesUNIV DUKE·Filed 2015·Application pending·0 cites
- 3447US2024299516A1Multilamellar rna nanoparticle vaccine against cancerUNIV OF FLORIDA RESEARCH FOUNDATON INC·Filed 2021·Application pending·0 cites
- 3547US2023226169A1Multilamellar rna nanoparticle vaccine against sars-cov-2UNIV FLORIDA·Filed 2021·Application pending·0 cites
- 3646US2021077399A1Magnetic liposomes and related treatment and imaging methodsUNIV FLORIDA·Filed 2019·Application pending·0 cites
- 3746US2023096704A1Rna-loaded nanoparticles and use thereof for the treatment of cancerUNIV FLORIDA·Filed 2021·Application pending·0 cites
- 3844US2011135637A1Trimodal cancer therapyUNIV DUKE·Filed 2010·Application pending·0 cites
- 3944US2022287969A1Multilamellar rna nanoparticlesUNIV FLORIDA·Filed 2020·Application pending·0 cites
- 4039US11464805B2CCR2+ hematopoietic stem cells mediate T cell activation in adoptive cell therapyUNIV FLORIDA·Filed 2017·Granted Oct 11, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Duane A. Mitchell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →